BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1693342)

  • 21. [Preparation and characterization of prodrugs of the potential schistosomicid praziquantel].
    Riera de Narváez AJ; Araujo S
    Acta Cient Venez; 1988; 39(5-6):451-6. PubMed ID: 3270297
    [No Abstract]   [Full Text] [Related]  

  • 22. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology.
    Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A
    Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of chemotherapy on the Schistosoma mansoni eggs].
    dos Reis MG; Andrade ZA
    Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between schistosomicidal drug efficacy, gonadal steroid hormonal changes and state of disease immunopathology in murine schistosomiasis mansoni.
    Botros SS; Salama SH; Estafan MY; Gomaa NE; Metwally AA; Ebeid FA
    Pharmacol Res; 1990; 22(3):359-70. PubMed ID: 2114615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nuclear basophilia and anisotropy in cells of mice treated with oxamniquine].
    Bechara IJ; Mello ML
    Rev Inst Med Trop Sao Paulo; 1984; 26(1):31-7. PubMed ID: 6463520
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 31. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene.
    Cioli D; Pica-Mattoccia L; Moroni R
    Exp Parasitol; 1992 Dec; 75(4):425-32. PubMed ID: 1493874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hycanthone on Schistosoma mansoni macromolecular synthesis in vitro.
    Mattoccia LP; Lelli A; Cioli D
    Mol Biochem Parasitol; 1981 Apr; 2(5-6):295-307. PubMed ID: 6165888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of hycanthone on nucleic acid synthesis by Schistosoma mansoni.
    Neame KD; Homewood CA; Marshall I; Jewsbury JM
    Ann Trop Med Parasitol; 1978 Dec; 72(6):587-8. PubMed ID: 736665
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of praziquantel and oxamniquine on prostacyclin synthesis by the rat arterial and myometrial tissues.
    el Tahir KE; al-Kharji AM; Ageel AM
    Gen Pharmacol; 1992 Jan; 23(1):131-9. PubMed ID: 1592222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hycanthone administered in vivo upon the incorporation of radioactive precursors into macromolecules of Schistosoma mansoni.
    Pica Mattoccia L; Cioli D
    Mol Biochem Parasitol; 1983 Jun; 8(2):99-107. PubMed ID: 6192338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.